Business Wire

AtriCure Completes Enrollment in LeAAPS Clinical Trial for Stroke Prevention

Largest cardiac surgery device trial ever with 6,500 patients enrolled, this landmark trial evaluates the stroke reduction benefit with AtriClip devices for the over one million cardiac surgery ...
Business Wire

AtriCure Announces that the First Patient has been Treated with the Revolutionary AtriClip ® FLEX-Mini™ Device

MASON, Ohio--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and ...
Seeking Alpha

AtriCure Announces the First Patient Treated in the BoxX-NoAF Clinical Trial

Trial will evaluate the safety and effectiveness of the AtriCure Isolator ® Synergy™ EnCompass ® clamp and AtriClip ® Left Atrial Appendage Exclusion System to reduce the occurrence of new-onset ...
MedPage Today

Surgical LAA Closure Rises to the Top in STS Guideline for Afib

SAN ANTONIO -- The Society of Thoracic Surgeons (STS) made a big push for left atrial appendage (LAA) occlusion in updated guidelines for the surgical treatment of atrial fibrillation (Afib). In this ...
Nasdaq

AtriCure Announces the First Patient Treated in the LeAAPS™ Clinical Trial

Trial will evaluate the safety and effectiveness of the AtriCure AtriClip® Left Atrial Appendage Exclusion System for stroke prevention in cardiac surgery patients LeAAPS is a prospective, randomized, ...